Detalhe da pesquisa
1.
Estimating the Cost of Thalassemia Care across the World: A Thalassemia International Federation Model.
Hemoglobin
; 46(6): 308-311, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36847683
2.
Exploring the current status of neuroendocrine tumours: a population-based analysis of epidemiology, management and use of resources.
BMC Cancer
; 19(1): 1226, 2019 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31842791
3.
The cost of lost productivity due to premature lung cancer-related mortality: results from Spain over a 10-year period.
BMC Cancer
; 19(1): 992, 2019 Oct 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-31646991
4.
Disability-adjusted-life-years losses in postmenopausal women with osteoporosis: a burden of illness study.
BMC Public Health
; 15: 324, 2015 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-25880810
5.
Prostate cancer in Spain: A retrospective database analysis of hospital incidence and the direct medical costs.
PLoS One
; 19(3): e0298764, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38451968
6.
Incidence and medical costs of lupus in Spanish hospitals: a retrospective database analysis.
Orphanet J Rare Dis
; 19(1): 74, 2024 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38365713
7.
A simulation model to estimate 10-year risk of coronary heart disease events in patients with schizophrenia spectrum disorders treated with second-generation antipsychotic drugs.
Ann Clin Psychiatry
; 25(1): 17-26, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23376866
8.
Incidence and medical costs of chronic obstructive respiratory disease in Spanish hospitals: a retrospective database analysis.
J Med Econ
; 26(1): 335-341, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36800217
9.
Direct medical costs of non-alcoholic fatty liver disease in Catalonia at the hospital level: a retrospective multicenter study.
Expert Rev Pharmacoecon Outcomes Res
; 22(2): 341-349, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33593235
10.
Ambulatory and hospital care of glaucoma in Spain and associated medical costs.
J Med Econ
; 25(1): 769-773, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35616280
11.
Hospital care and medical costs of septic arthritis in Spain: a retrospective multicenter analysis.
J Med Econ
; 25(1): 381-385, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35236216
12.
Hospital incidence and medical costs of polycythemia vera in Spain: a retrospective database analysis.
Expert Rev Pharmacoecon Outcomes Res
; 22(6): 965-970, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35034517
13.
Economic Implications of Endometriosis: A Review.
Pharmacoeconomics
; 40(12): 1143-1158, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36344867
14.
Chronic inflammatory demyelinating polyneuropathy in Spain: a retrospective analysis of hospital incidence and medical costs.
Expert Rev Pharmacoecon Outcomes Res
; 22(4): 665-670, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34720023
15.
Hospital care of endometriosis in Spain: a retrospective multicenter analysis of patient characteristics and costs.
Expert Rev Pharmacoecon Outcomes Res
; 22(3): 481-488, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34043465
16.
Hospital incidence and costs of congenital hydrocephalus in Spain: a multicenter retrospective study.
Expert Rev Pharmacoecon Outcomes Res
; 22(5): 877-881, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35085473
17.
Burden of ischemic heart disease in Spain: incidence, hospital mortality and costs of hospital care.
Expert Rev Pharmacoecon Outcomes Res
; 22(7): 1147-1152, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36001004
18.
Hospital incidence, in-hospital mortality and medical costs of pneumococcal disease in Spain (2008-2017): a retrospective multicentre study.
Curr Med Res Opin
; 37(3): 523-530, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33459058
19.
Burden of Hodgkin and non-Hodgkin lymphoma in Spain over a 10-year period: productivity losses due to premature mortality.
Expert Rev Pharmacoecon Outcomes Res
; 21(1): 87-92, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-32450710
20.
Analysis of hospital incidence and direct medical costs of intrahepatic cholangiocarcinoma in Spain (2000-2018).
Expert Rev Pharmacoecon Outcomes Res
; 21(3): 425-431, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33161795